Title |
Abdominopelvic FLASH Irradiation Improves PD-1 Immune Checkpoint Inhibition in Preclinical Models of Ovarian Cancer
|
---|---|
Published in |
Molecular Cancer Therapeutics, February 2022
|
DOI | 10.1158/1535-7163.mct-21-0358 |
Pubmed ID | |
Authors |
Joshua T Eggold, Stephanie Chow, Stavros Melemenidis, Jinghui Wang, Suchitra Natarajan, Phoebe E Loo, Rakesh Manjappa, Vignesh Viswanathan, Elizabeth A Kidd, Edgar Engleman, Oliver Dorigo, Billy W Loo, Erinn B Rankin |
X Demographics
The data shown below were collected from the profiles of 21 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 11 | 52% |
Spain | 1 | 5% |
Netherlands | 1 | 5% |
Turkey | 1 | 5% |
Unknown | 7 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 13 | 62% |
Scientists | 4 | 19% |
Science communicators (journalists, bloggers, editors) | 2 | 10% |
Practitioners (doctors, other healthcare professionals) | 2 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 31 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 7 | 23% |
Researcher | 7 | 23% |
Unspecified | 3 | 10% |
Other | 2 | 6% |
Lecturer | 2 | 6% |
Other | 4 | 13% |
Unknown | 6 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 6 | 19% |
Medicine and Dentistry | 5 | 16% |
Agricultural and Biological Sciences | 4 | 13% |
Unspecified | 3 | 10% |
Physics and Astronomy | 2 | 6% |
Other | 3 | 10% |
Unknown | 8 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2023.
All research outputs
#2,107,435
of 24,079,942 outputs
Outputs from Molecular Cancer Therapeutics
#235
of 3,944 outputs
Outputs of similar age
#52,733
of 509,744 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#4
of 66 outputs
Altmetric has tracked 24,079,942 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,944 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 509,744 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.